Drug Shortage Report for MEZAVANT

Last updated on 2022-08-05 History
Report ID 164835
Drug Identification Number 02297558
Brand name MEZAVANT
Common or Proper name Mesalamine delayed- and extended-release tablets
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) MESALAZINE
Strength(s) 1.2G
Dosage form(s) TABLET (DELAYED AND EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 120 tablets / bottle
ATC code A07EC
ATC description INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-07-18
Actual start date 2022-07-18
Estimated end date 2022-08-19
Actual end date
Shortage status Actual shortage
Updated date 2022-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-08-05 French Compare
v3 2022-08-05 English Compare
v2 2022-07-18 French Compare
v1 2022-07-18 English Compare

Showing 1 to 4 of 4